Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Pilots want to live too

Krönika: Collaboration across borders

Drug development creates new challenges for regulators

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish governments, the timing of The Future of Swedish & Danish Life Science conference could not be better. A one-day conference on ongoing collaborations, new directions and required future investment will held on April 2nd at Medicon Village in Lund.

Framtidens laboratorium i fokus på fackmässan Analytica

Messe München laddar för att återigen ta emot världens laboratoriebransch

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and research could become a reality. Kajsa M Paulsson is the project leader for HALOS, driving the idea forward.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life science village is home to over 150 organisations, employing more than 2,200 people.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards an exit early 2020.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of Development at Spago Nanomedical says.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma Outsourcing Dec 10th i Stockholm. This is her thoughts about outsourcing.

Nya delar i mänsklig atlas

Nu lanseras tre nya delar i jätteprojektet att kartlägga människans proteiner. Alla proteiner i människans blodceller, hjärnan och kroppens ämnesomsättning har nu sammanställts i den mänskliga atlasen.

Efter Senzagen: Här är Anki Malmborg Hagers nya vd-jobb

Ska leda e-hälsobolag för smärthantering.

Långt gånget för Index studie

Patientrekryteringen klar för dosoptimeringsstudien Conduct där Index pharmaceuticals kandidat för behandling av ulcerös kolit utvärderas.

Ihop ska de förbättra följsamheten hos patienten

Sandoz och Pilloxa samarbetar för att förbättra följsamheten till medicinering hos transplanterade patienter med hjälp av en smart läkemedelsdosett.

Ett steg närmare ett medel mot åldrande

Med en ny metod kan KI-forskarna ha hittat ett nytt medel mot åldrande.

App för blödarsjuka

Nu lanseras en app som gör det möjligt för blödarsjuka att följa sina egna beräknade faktor VIII-nivåer direkt i mobilen för att undvika att nivåerna låga.

Abbott och Novo Nordisk i diabetessamarbete

Bolagens produkter ska börja tala med varandra för att skapa en integrerad digital lösning för diabetiker som använder insulin.

Serialisering av läkemedelsförpackningar igång

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duties of the Life Sciences office are plentiful.